The chemical element selenium, an essential nutrient for humans and other animals, protects the brain after a stroke and may be a basis for future stroke therapies, according to a study from scientists at Burke Neurological Institute and Weill Cornell Medicine.
A team of scientists have discovered that selenium, a micronutrient, can help boost the antioxidant system on the heels of stroke in animals and suggests that a similar treatment could be used to limit brain damage in patients. Stroke is a leading cause of disability and death in the United States, occurring once every 40 seconds.
Blythedale Children’s Hospital and Burke Neurological Institute announce the appointment of Dianna E. Willis, Ph.D., as Director of Research for the Burke-Blythedale Pediatric Neuroscience Research Collaboration.
The Burke Neurological Institute, the University of Rochester Medical Center and Wadsworth Center of the NYS Department of Health (NYSDOH) were recently awarded a $5 million grant from the Empire State Development Corporation to enable NeuroCuresNY (NCNY) to launch a two-year pilot starting in January 2020.
Burke Neurological Institute is collaborating with U.S. Military Academy at West Point to give cadets majoring in pre-med hands-on experience in basic and clinical research.
Weill Cornell Medicine Office of Diversity and Inclusion, in New York, New York
Dr. Victor Wong, postdoctoral fellow of the Laboratory for Axonal and RNA Biology at Burke Neurological Institute, has been selected as the recipient of the 2019 Pioneers in Diversity Louis Wade Sullivan, M.D. Award.
